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CounselingAbstract Background: In asthma, the preventive measures taken by patients play an important role
in improving life span and quality of life. This can be done more efﬁciently by community pharma-
cist by providing patient counseling and improving knowledge of patient about disease, risk factors,
medication management and preventive measures to control asthma. Objectives: The objective of
the study was to evaluate the contribution of community pharmacists in improvement of life span
and quality of life of asthma patients. Method: The study was performed from Mid September to
Mid-November 2014 in Dawadmi, Riyadh province, KSA. Data were collected by using a
structured face to face questionnaire with randomly selected different community pharmacies.
The questionnaire composed of different closed questions about the action plan of pharmacists
in asthma management and factors that affect the counseling of asthma patients by the pharmacists.
Results: It is noteworthy to observe that, in general, pharmacists are sufﬁciently knowledgeable and
competent to counsel their asthma patients effectively.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Asthma is a signiﬁcant public health issue worldwide. The
correct management of asthma requires a multidisciplinary
approach that includes the doctor, the patient and the patient’s
family. To optimize asthma management, internationalrecommendations have been published (NHLBI/WHO
Workshop Report. NIH publication 95–3659: Aı¨t-Khaled
and Enarson, 2005, 2006). Despite these progresses, asthma-
related morbidity and mortality remain high (Ganyere et al.,
1998). Today, asthma can be considered a condition that is
not perfectly managed, since deaths due to this illness are
usually from preventable causes, including poor treatment
and observation (Kofﬁ et al., 2001). Disease management
programs are one of the clinical services being offered by
pharmacists, and these particularly lend themselves to chronic
conditions, such as asthma and diabetes (Boulet et al., 2002;
Haahtela, 2002). Underpinning these new trends in the practice
of pharmacy is the philosophy of pharmaceutical care that
calls for pharmacists to take responsibility for patient’s clinical
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most accessible health-care professionals in the desire to coun-
sel primary care setting. Their frequent contact with patients
due to the need for prescription reﬁlls, and their expertise in
medication, ensures that they are optimally positioned to pos-
itively impact on asthma management (Mehuys et al., 2008;
Hepler and Strand, 1990). Therefore the present study, aimed
to assess the attitudes of private pharmacists toward asthma
patients in Al-Dawadmi and its surrounding area, with the fol-
lowing objectives: To evaluate about the prescriptions known
for asthma patients; to evaluate pharmacists’ knowledge of
inhalation techniques and to describe the advice given by phar-
macists to asthma patients.
2. Methodology
2.1. Study site
A survey among community pharmacists in Al-Dawadmi,
Riyadh province, KSA, was conducted over a period of one
month from Mid-September to Mid-October 2014. Data
collection was carried out using a structured face-to-face
questionnaire with 20 randomly selected community pharmacies
from different areas of Al-Dawadmi region.
2.2. The questionnaire
A modiﬁed questionnaire from a previous report was prepared
(NIH, 1995). The questionnaire included eight closed ques-
tions to pharmacists toward the contribution of dispensing
process. The survey was conducted by a single investigator,
who systematically met with the chief pharmacists to explain
the objectives of the survey before administering the question-
naire. Apart from the rare cases where the pharmacist
responded on the spot, the investigator was often obliged to
return at a time suitable for the pharmacist.
The ﬁrst two questions were about the education of patho-
physiology of asthma to a patient by pharmacists. QuestionsTable 1 The list of questions used for the survey.
.Q Paramater
1 Are you educating patient basic fact about asthma? What
normal lung and asthma attack?
2 Can you identify and manage the triggers of asthma for
the patient?
3. Which drug is widely prescribing medication by the doctor
4 Are you following eﬀective asthma management plan
ensure the patient is given written and verbal instructions
that describe:
5 Are you educated patient about the role of each
medication?
6 Are you explaining about the side eﬀect and adverse drug
reaction to the particular use of drug
7 Are you asking the patient about medication other than
the asthma medication?
8 Have you educated the patient about the proper
techniques of inhaled medication?three and four dealt with type and which drug prescribed by
a doctor to dispensing drugs by the pharmacists. Question ﬁve
asks the pharmacists about the asthma management plan
ensure the patient is given written and verbal instructions that
describe, when the patient takes drug, how the intervention
patient takes drug; how much and when to seek medication
cure to take. Questions six to eight explain about the role of
each medication, side effect, adverse drug reaction and any
drugs other than asthma medication. The last question is
about knowledge of inhalation technique (Table 1).
Second part of survey, asked respondents to indicate their
level of agreement with a number of statements which identi-
ﬁed factors/situations that could potentially inﬂuence pharma-
cists’ desire/ability to counsel their asthma patients (Buckley
and Ryder, 2012). The concept of research and its impact in
improving health care are partly understood by Dawadmi
community pharmacists. Therefore, a close ended and simple
question format was chosen to enable the pharmacists to
answer easily and promptly (Table 2).
2.3. Data collection and analysis
The pharmacists were interviewed inside the community phar-
macies after getting the agreement of the pharmacists. The
purpose of the study was explained to each pharmacist and
they were invited to complete the questionnaire after assuring
the willingness to participate. The survey responses were trea-
ted anonymously and conﬁdentially. Upon receipt of the com-
pleted questionnaires the% response of each variable was
calculated.
3. Results and discussion
Since asthma is an allergic disease, preventive measures taken
by patients play an important role in improving life span and
quality of life which can be done more efﬁciently by clinical
pharmacists by providing patient counseling through improv-
ing knowledge of patient about disease, risk factors,Category Answer
Yes/No
Yes/No
 b Blocker & Bronchodilator
 Corticosteroid
 Leukotriene modiﬁers
 Anti-inﬂammatory
 When the patient takes drug
 How the patient takes drug
 How much
 When to seek medication cure to take
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Table 2 Factors that affect the counseling of an asthma patient by the community pharmacist.
Q Parameter Answer
1 Time is a major limitation Yes/No
2 Patients are receptive to counseling Yes/No
3 I have suﬃcient knowledge to counsel eﬀectively Yes/No
4 I am not competent to educate on inhalation technique Yes/No
5 I am not competent to educate on peak ﬂow meter usage Yes/No
6 Not my role to counsel to improve asthma control Yes/No
7 I do not counsel; I am underpaid to do so Yes/No
Contribution of community pharmacists 687medication management and preventive measures to control
asthma (Ratham et al., 2013). As there is no cure for asthma,
the key instrument is to educating the people about asthma.
Pharmacist education was also found to be key variable in
assessing the knowledge of disease. Patient counseling has
corner stone for pharmaceutical care and improves patient’s
quality of life. In the present study, we asked the pharmacists
to indicate their level of involvement in educating the patient
about asthma and its pathophysiology followed by medication
and its management, also to determine the opinions of commu-
nity pharmacists about the current level of asthma manage-
ment among their asthma patients (Figs. 1–3). Further,
questions were included to explore the level of counseling that1
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Ryder, 2012). For optimum patient care appropriate
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of responses rate was very high. This indicates majority of the
pharmacists are well competitive enough in intervening the
asthma patient with their basic knowledge. Drugs such as
anti-inﬂammatory agents, leukotriene modiﬁers, corticosteroid
and b-blocker are the agents used for the treatment of asthma.
In the present study, we asked the pharmacists to report, the
widely prescribed medication for an asthma patient during
counseling. The results indicate 60% pharmacists say b-
blocker is widely prescribed drug for the treatment of asthma,
another 25% pharmacists say corticosteroid, 10% of pharma-
cists say anti-inﬂammatory agents and 5% say leukotriene
modiﬁers. Fig. 3 represents the % of responses in asthma man-
agement plan such as when, how and how much to take drug.
Majority of the respondents are agreed in conveying the mes-
sage of action plan for the asthma during their counseling.
From these results it is evident that pharmacists have sufﬁcient
knowledge and they are competitive enough to educate patient
in the management of asthma.
It is apparent from Fig. 4 that, for the majority of respon-
dents, time is the factor of greatest inﬂuence with regard to
pharmacists’ ability to counsel asthma patients. It is notewor-
thy to observe that, in general, pharmacists are sufﬁciently
knowledgeable and competent to counsel their asthma patients
effectively (Fig. 4).4. Conclusion
The present study has revealed a number of salient points.
Firstly, community pharmacists believe that, on the whole,
their patients’ level of asthma management is optimal. In an
attempt to improve this situation, there is a need to broaden
pharmacists’ perceptions of their role in asthma management
beyond counseling primarily on the medications dispensed.
However, as time is a major factor inﬂuencing pharmacists’
ability to counsel, signiﬁcant changes are needed within com-
munity pharmacy that will facilitate pharmacists using their
professional skills to become more actively involved in patient
care and disease management and moving away from the tra-
ditional role of medication supply.
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